
Civilization VC
1.5K posts

Civilization VC
@CivilizationVC
We accelerate (AI) breakthroughs that will define human health + civilization for the next century. Founded by @ShahramSN. RTs/likes ≠ endorsements. 🩺 🧬 AI




Today we release Rhaister, an elegant statistical model that predicts drug phenotypes in new contexts w/ accuracies comparable to experimental assays. And dropping Emerald Bay, a 2M cell dataset measuring long time-course phenotypes across 1000s of drug-cell line interactions.










I'm lucky enough to have a great doctor and access to excellent Bay Area medical care. I've taken lots of standard screening tests over the years and have tried lots of "health tech" devices and tools. With all this said, by far the most useful preventative medical advice that I've ever received has come from unleashing coding agents on my genome, having them investigate my specific mutations, and having them recommend specific follow-on tests and treatments. Population averages are population averages, but we ourselves are not averages. For example, it turns out that I probably have a 30x(!) higher-than-average predisposition to melanoma. Fortunately, there are both specific supplements that help counteract the particular mutations I have, and of course I can significantly dial up my screening frequency. So, this is very useful to know. I don't know exactly how much the analysis cost, but probably less than $100. Sequencing my genome cost a few hundred dollars. (One often sees papers and articles claiming that models aren't very good at medical reasoning. These analyses are usually based on employing several-year-old models, which is a kind of ludicrous malpractice. It is true that you still have to carefully monitor the agents' reasoning, and they do on occasion jump to conclusions or skip steps, requiring some nudging and re-steering. But, overall, they are almost literally infinitely better for this kind of work than what one can otherwise obtain today.) There are still lots of questions about how this will diffuse and get adopted, but it seems very clear that medical practice is about to improve enormously. Exciting times!



Last year I visited @Tubulis_GmbH in Munich, Germany. Here's what CEO Dominik Schumacher told me they were aiming to do. Congrats on today's acquisition by @gilead for up to $5B, and congrats to @schroederthilo who raved to me about this company.




Today is a BIG day for @RocketPharma — and for my firm @CivilizationVC!!! An FDA approved drug. 🚀🧬 The FDA granted accelerated approval to Rocket gene therapy for the severe form of a rare immune disorder called leukocyte adhesion deficiency-I (LAD-I). "LAD-I is caused by mutations in the ITGB2 gene and leads the immune system to stop working properly. Patients with severe disease face serious and potentially deadly bacterial and fungal infections. Currently, the only potential cure is stem cell transplant from a donor, but that bears its own serious risks. The gene therapy involves extracting a young patient’s own blood stem cells and modifying them in the lab to introduce functional copies of the gene. Patients then receive conditioning to clear out their bone marrow, after which the modified cells are infused back in hopes of giving them a working immune system." Congratulations to the Rocket team on this milestone! FDA approves Rocket's gene therapy for ultra-rare immune disease - endpoints.news/fda-approves-r…

